{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:29:42Z","timestamp":1794626982326,"version":"4.9.1"},"reference-count":63,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["20DZ2261200"],"award-info":[{"award-number":["20DZ2261200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["20XD1401200"],"award-info":[{"award-number":["20XD1401200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["20Z11901000"],"award-info":[{"award-number":["20Z11901000"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070045"],"award-info":[{"award-number":["82070045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130001"],"award-info":[{"award-number":["82130001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["febs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Molecular Oncology"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>Although first\u2010line alectinib has prolonged survival in <jats:italic>ALK\u2010<\/jats:italic>mutated non\u2010small\u2010cell lung cancers (NSCLCs), the response to treatment varies among patients, and the primary\/early development of alectinib resistance mechanisms is still not fully understood. Here, we analyzed molecular profiles of 108 alectinib\u2010treated patients (first\u2010line and second\u2010line after crizotinib) with confirmed relapse by targeted sequencing of cancer\u2010related genes. After first\u2010line treatment, off\u2010target <jats:italic>MET<\/jats:italic> and <jats:italic>NF2<\/jats:italic> alterations were more frequent than on\u2010target alterations within the first 6\u2009months, causing primary or early resistance. Conversely, on\u2010target alterations became prevalent after 1\u2009year of first\u2010line alectinib treatment and predominantly after second\u2010line. The incidence of acquired resistance also depended on <jats:italic>EML4\u2010ALK<\/jats:italic> variants. In variant 1 (v1), off\u2010target alterations were responsible for 50% of resistance cases after first\u2010line alectinib therapy, whereas on\u2010target mutations had no contribution in this subgroup. In variant 3 (v3), on\u2010target alterations resulted in 46% of resistance cases, whereas only 18% were caused by off\u2010target mutations. After second\u2010line treatment, the most common mutations in v1 were L1196M (42%) and G1269A (25%), while G1202R was detected in 45% of v3 tumors. These findings emphasize the importance of stratifying resistance mechanisms to guide tailored treatment for <jats:italic>ALK<\/jats:italic>\u2010positive NSCLCs.<\/jats:p>","DOI":"10.1002\/1878-0261.70029","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T12:33:49Z","timestamp":1743597229000},"page":"2715-2729","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["<i>MET<\/i> and <i>NF2<\/i> alterations confer primary and early resistance to first\u2010line alectinib treatment in <i>ALK<\/i>\u2010positive non\u2010small\u2010cell lung cancer"],"prefix":"10.1002","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5858-6169","authenticated-orcid":false,"given":"Jie","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Pulmonary Medicine Shanghai Geriatric Medical Center  China"},{"name":"Department of Pulmonary Medicine, Zhongshan Hospital Fudan University  Shanghai China"},{"name":"Shanghai Respiratory Research Institute  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Zhongshan Hospital Fudan University  Shanghai China"},{"name":"Shanghai Respiratory Research Institute  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Zhongshan Hospital Fudan University  Shanghai China"},{"name":"Shanghai Respiratory Research Institute  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7942-5540","authenticated-orcid":false,"given":"Yedan","family":"Chen","sequence":"additional","affiliation":[{"name":"Geneseeq Research Institute Nanjing Geneseeq Technology Inc.  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Zhongshan Hospital Fudan University  Shanghai China"},{"name":"Shanghai Respiratory Research Institute  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Liu","sequence":"additional","affiliation":[{"name":"Geneseeq Research Institute Nanjing Geneseeq Technology Inc.  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiebai","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Zhongshan Hospital Fudan University  Shanghai China"},{"name":"Shanghai Respiratory Research Institute  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairong","family":"Bao","sequence":"additional","affiliation":[{"name":"Geneseeq Research Institute Nanjing Geneseeq Technology Inc.  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine Shanghai Geriatric Medical Center  China"},{"name":"Department of Pulmonary Medicine, Zhongshan Hospital Fudan University  Shanghai China"},{"name":"Shanghai Respiratory Research Institute  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Zhongshan Hospital Fudan University  Shanghai China"},{"name":"Shanghai Respiratory Research Institute  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shao","sequence":"additional","affiliation":[{"name":"Geneseeq Research Institute Nanjing Geneseeq Technology Inc.  China"},{"name":"School of Public Health Nanjing Medical University  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanlin","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine Shanghai Geriatric Medical Center  China"},{"name":"Department of Pulmonary Medicine, Zhongshan Hospital Fudan University  Shanghai China"},{"name":"Shanghai Respiratory Research Institute  China"},{"name":"Shanghai Key Laboratory of Lung Inflammation and Injury, Department of Pulmonary Medicine, Zhongshan Hospital Fudan University  Shanghai China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,4]]},"reference":[{"issue":"2","key":"e_1_2_11_2_1","first-page":"156","article-title":"Beyond ALK\u2010RET, ROS1 and other oncogene fusions in lung cancer","volume":"4","author":"Kohno T","year":"2015","journal-title":"Transl Lung Cancer Res"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1704795"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30565-2"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy121"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.04.478"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00515-0"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.8732"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.2294"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature05945"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0596"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-1123"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02236"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2021.04.008"},{"issue":"4","key":"e_1_2_11_15_1","article-title":"Acquired exon 14 MET mutation associated with resistance to alectinib in a patient with ALK\u2013rearranged NSCLC","volume":"1","author":"Daniel C","year":"2020","journal-title":"JTO Clin Res Rep"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-1010"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3906"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt127"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408440"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.34070"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty560"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp324"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btv098"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1101\/gr.107524.110"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1101\/gr.129684.111"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq603"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu549"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-732"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2883"},{"key":"e_1_2_11_30_1","unstructured":"SmithM.timescape: Patient Clonal Timescapes. R package version 1.22.0.2023.https:\/\/bioconductor.org\/packages\/release\/bioc\/html\/timescape.html"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2023.100483"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.9092"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0573-8"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3563"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2022.07.113"},{"key":"e_1_2_11_36_1","doi-asserted-by":"crossref","first-page":"S1420","DOI":"10.1016\/j.annonc.2022.08.055","article-title":"LBA53 ELIOS: a multicentre, molecular profiling study of patients (pts) with epidermal growth factor receptor\u2010mutated (EGFRm) advanced NSCLC treated with first\u2010line (1L) osimertinib","volume":"33","author":"Piotrowska Z","year":"2022","journal-title":"Ann Oncol"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2027187"},{"key":"e_1_2_11_38_1","doi-asserted-by":"crossref","first-page":"S1014","DOI":"10.1016\/j.annonc.2022.07.1134","article-title":"1008P resistance mechanisms to lorlatinib or crizotinib in treatment\u2010naive patients (pts) with ALK+ advanced non\u2010small cell lung cancer (NSCLC)","volume":"33","author":"Felip E","year":"2022","journal-title":"Ann Oncol"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078\u20100432.CCR\u201019\u20101436"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-1256"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-022-00399-6"},{"issue":"1","key":"e_1_2_11_42_1","first-page":"100116","article-title":"A novel sequentially evolved EML4\u2010ALK variant 3 G1202R\/S1206Y double mutation in cis confers resistance to lorlatinib: a brief report and literature review","volume":"2","author":"Zhu VW","year":"2021","journal-title":"JTO Clin Res Rep"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1141478"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078\u20100432.CCR\u201021\u20100032"},{"issue":"3","key":"e_1_2_11_45_1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/onco.13545","article-title":"Acquired MET D1228N mutations mediate crizotinib resistance in lung adenocarcinoma with ROS1 fusion: a case report","volume":"26","author":"Wang Y","year":"2021","journal-title":"Oncologist"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.09.015"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.03.020"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-2278"},{"issue":"1","key":"e_1_2_11_49_1","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/s41467-022-28848-x","article-title":"The evolution of RET inhibitor resistance in RET\u2010driven lung and thyroid cancers","volume":"13","author":"Rosen EY","year":"2022","journal-title":"Nat Commun"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3001"},{"issue":"8","key":"e_1_2_11_51_1","article-title":"Efficacy and tolerability of ALK\/MET combinations in patients with ALK\u2010rearranged lung cancer with acquired MET amplification: a retrospective analysis","volume":"4","author":"Dagogo\u2010Jack I","year":"2023","journal-title":"JTO Clin Res Rep"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24455"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205693"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.125"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAT.0b013e32834c3599"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040927"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.04.014"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-17-0104"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-1104"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1322892111"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw693"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.08.003"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.12.022"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2022.07.011"}],"container-title":["Molecular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/1878-0261.70029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T04:22:33Z","timestamp":1757478153000},"score":1,"resource":{"primary":{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/10.1002\/1878-0261.70029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":63,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1002\/1878-0261.70029"],"URL":"https:\/\/doi.org\/10.1002\/1878-0261.70029","archive":["Portico"],"relation":{},"ISSN":["1574-7891","1878-0261"],"issn-type":[{"value":"1574-7891","type":"print"},{"value":"1878-0261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"2024-10-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}